]>
IRCT20130811014330N6 IRCT 2019-06-02 Mashhad University of Medical Sciences,vice chancellor for research The effect of curcumin on neurological complications of diabetes and HbA1c levels The effect of curcumin on neurological complications of diabetes and HbA1c levels 2018-04-21 anticipated 120 Complete https://irct.ir/trial/13934 interventional Randomization: Not randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Blinding description: First, all patients with type 2 diabetes in 2 medical diagnostic laboratories in the city of Mashhad are examined. 120 patients who are diagnosed with diabetic neuropathy are selected. Patients are divided into two groups of 60 people. The first group is the case and the second group is the control. The first group is given a nano-curcumin capsule and second group, placebo capsules. During the course of the project, both groups are unaware of the type of capsule. Researchers are not aware of the type of capsule during the execution of the project. The appearance and taste of the main drug and the placebo are quite similar and are coded in a special way. N/A diabetic individuals with neuropathic disorders. Intervention 1: "Intervention :"This group receives 1 capsule of sinacurcumin every day.at the end of the 3-month period, a laboratory profile similar to the beginning of the course are created for each patient. The results are examined, analyzed and compared. Intervention 2: Control group: patients receive placebo at similar intervals. Yes - There is a plan to make this available What will be shared: Study data will be published in the form of a scientific paper upon completion of the project. When: Access to data and results is coincident with the publication of scientific articles in prestigious journals. To whom: Individual access is determined in accordance with the authorizations allowed by the publisher of the article. Conditions: For this, researchers must contact the co-responding author of the article. Where to obtain: co-responding author of the article. How to obtain: Communicate with the co-responding author of the article through the communication channels announced. Comments:
public Hamidreza Rahimi
Faculty of Medicine, Azadi Square, Pardis Campus, Mashhad-Iran
Mashhad Iran (Islamic Republic of) 9137913316 +98 51 3800 2301 rahimihr@mums.ac.ir Mashhad university of medical sciences scientific Dr Hamidreza Rahimi & Dr.Zahra Mazlum khorasani
Faculty of Medicine, Azadi Square, Pardis Campus, Mashhad-Iran, Mashhad
Mashhad Iran (Islamic Republic of) 9137913316 +98 51 3800 2301 rahimihr@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) Diabetes mellitus with neuropathy (gloves and socks) Age range of 70-18 years, at least five years with illness The same type of medication used, Taking oral medicine no limit no limit Both Age over 70 years and under 18 years Taking insulin E11.4 Type 2 diabetes mellitus with neurological complications Treatment - Drugs Placebo "Intervention :"This group receives 1 capsule of sinacurcumin every day.at the end of the 3-month period, a laboratory profile similar to the beginning of the course are created for each patient. The results are examined, analyzed and compared. Control group: patients receive placebo at similar intervals. HbA1c. Timepoint: before and after using curcumin. Method of measurement: electrophoresis. 2. The lab profile includes Lip a, BUN, U / A, Cr, FBS, TG, TC, HDL, LDL. Timepoint: Before and after using curcumin. Method of measurement: Spectrophotometry using an autoanalyzer. Mashhad University of Medical Sciences,vice chancellor for research Approved 2018-06-27 Mashhad University of Medical Sciences Knowledge and Health City – In the end of Shahid Fakouri Blvd (In front of Fakouri 94) – Mashhad - Iran Mashhad Razavi Khorasan Iran (Islamic Republic of)